$5.92 (11.70%)

Volume: 2.769M

Closed: Jan 27, 2023

Hollow Logo Score: -1.672
Fate Therapeutics Stock
$5.92 (11.70%)

Volume: 2.769M

Closed: Jan 27, 2023

Score Hollow Logo -1.672
NASDAQ:FATE

Fate Therapeutics Stock Price (Quote)

$5.92 ( 11.70% ) Friday, 27th Jan 2023

Range Low Price High Price Comment
30 days $4.02 $11.44 Friday, 27th Jan 2023 FATE stock ended at $5.92. This is 11.7% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 14.48% from a day low at $5.25 to a day high of $6.01.
90 days $4.02 $23.96
52 weeks $4.02 $43.12

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2023-01-27 $5.29 $6.01 $5.25 $5.92 2 768 809
2023-01-26 $5.48 $5.49 $5.16 $5.30 1 946 675
2023-01-25 $5.34 $5.45 $5.17 $5.40 2 599 180
2023-01-24 $5.42 $5.60 $5.35 $5.43 2 643 405
2023-01-23 $5.59 $5.68 $5.33 $5.55 3 929 416
2023-01-20 $5.78 $5.80 $5.45 $5.47 3 041 388
2023-01-19 $5.77 $5.88 $5.59 $5.65 2 785 538
2023-01-18 $5.78 $5.91 $5.60 $5.81 3 120 214
2023-01-17 $5.73 $5.86 $5.57 $5.72 4 293 339
2023-01-13 $5.83 $5.90 $5.38 $5.40 3 002 631
2023-01-12 $5.73 $5.87 $5.35 $5.86 2 612 842
2023-01-11 $5.49 $5.78 $5.32 $5.72 3 940 100
2023-01-10 $5.15 $5.49 $5.07 $5.49 5 737 300
2023-01-09 $4.32 $5.57 $4.30 $5.27 14 466 800
2023-01-06 $4.38 $4.55 $4.02 $4.24 33 525 200
2023-01-05 $11.24 $11.44 $10.54 $11.00 3 850 967
2023-01-04 $10.42 $11.40 $10.38 $11.12 7 446 980
2023-01-03 $9.94 $10.75 $9.92 $10.17 10 036 766
2022-12-30 $9.85 $10.20 $9.56 $10.09 6 496 750
2022-12-29 $10.01 $10.16 $9.79 $10.00 9 019 407
2022-12-28 $10.14 $10.44 $9.79 $9.86 3 383 656
2022-12-27 $10.90 $11.07 $9.88 $10.20 3 754 089
2022-12-23 $11.66 $11.67 $10.89 $11.01 2 501 052
2022-12-22 $11.55 $11.75 $10.95 $11.66 3 330 524
2022-12-21 $12.75 $13.00 $12.15 $12.25 1 984 568
2022-12-20 $12.64 $12.88 $12.41 $12.63 1 753 253
2022-12-19 $13.08 $13.15 $12.43 $12.75 2 164 668
2022-12-16 $14.00 $14.11 $12.94 $13.08 5 375 978
2022-12-15 $14.49 $15.05 $13.91 $14.21 2 257 586
2022-12-14 $16.33 $16.43 $15.21 $15.37 2 144 976
2022-12-13 $17.35 $17.63 $15.35 $16.37 2 856 401
2022-12-12 $16.88 $17.01 $14.84 $16.20 4 890 842
2022-12-09 $19.00 $19.57 $18.71 $18.90 752 484
2022-12-08 $19.42 $19.42 $18.57 $19.12 1 126 692
2022-12-07 $19.01 $19.40 $18.79 $19.10 966 364
2022-12-06 $20.40 $20.73 $19.03 $19.14 1 133 796
2022-12-05 $20.90 $21.10 $20.02 $20.40 1 112 663
2022-12-02 $19.79 $20.93 $19.48 $20.91 1 366 245
2022-12-01 $20.88 $21.47 $19.95 $20.34 836 626
2022-11-30 $19.98 $21.07 $19.41 $20.82 1 423 453
2022-11-29 $19.34 $20.71 $19.13 $19.84 1 420 774
2022-11-28 $19.73 $20.14 $19.11 $19.26 713 695
2022-11-25 $19.42 $19.99 $19.15 $19.83 333 978
2022-11-23 $19.76 $20.74 $19.50 $19.65 813 604
2022-11-22 $19.65 $19.68 $18.86 $19.55 610 202
2022-11-21 $19.68 $20.07 $19.28 $19.40 446 753
2022-11-18 $20.63 $20.63 $19.73 $19.79 569 576
2022-11-17 $20.10 $20.41 $19.66 $19.87 588 714
2022-11-16 $21.92 $22.05 $20.18 $20.50 935 346
2022-11-15 $23.35 $23.96 $21.90 $22.58 747 691

Hot Stocks To Watch:

About Fate Therapeutics

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT